Medchemexpress LLC 4-[[[[[2,6-dichloro-2'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]amino]carbonyl]amino]methyl]benzeneace | 2170477-75-3 | 98.1% | C23H17Cl2F3N2O4 | 10MG

Supplier:  Medchemexpress LLC HY13133810MG

RORγt inverse agonist 13 is a potent, orally active, and selective inverse agonist of the retinoic acid-related orphan receptor γt (RORγt), characterized for preclinical research use. The compound has been profiled for potency, purity, solubility, and storage stability to support in vitro and in vivo studies.

• Potent RORγt inverse agonist with an IC50 of 63.8 nM.
• Orally active and selective for RORγt.
• High purity (~98.1%) suitable for research applications.
• Supplied as a white to off-white solid for convenient handling.
• Highly soluble in DMSO (100 mg/mL) for in vitro assays.
• Formulation demonstrated ≥2.5 mg/mL in 10% DMSO/90% corn oil for in vivo dosing.
• Stable as a powder at -20°C for long-term storage.
• Intended for research use only; not for human therapeutic use.

Catalog No. 50-002-59633